期刊文献+

P53 ser249突变对小鼠ES细胞细胞周期和凋亡的影响 被引量:1

The effect of p53 249 Arg to Ser mutation on the cell cycle and apoptosis in mouse ES cell
下载PDF
导出
摘要 目的研究p53249编码子突变对p53结构、功能和信号传导的影响。方法利用基因打靶技术,在小鼠ES细胞p53基因249编码子中引入点突变,使编码子249由Arg变成Ser,根据同源重组规律,采用PCR或Southern杂交方法,筛选带有p53249突变的阳性ES细胞,并通过测序确定该ES细胞的p53249编码子已经由Arg变成Ser。利用细胞流式仪检测该突变对细胞周期及凋亡的影响,并利用Western印迹检测相关蛋白的表达。结果①用IR处理细胞后,含p53249编码子突变的ES细胞凋亡百分数,较含野生型p53的ES细胞凋亡百分数明显减少,P<0.05。②用IR处理细胞后,含p53249编码子突变的ES细胞对IR诱导的G1/G0细胞周期阻滞作用减弱。③与含野生型p53的ES细胞相比,用IR处理细胞后,含p53249编码子突变ES细胞的p53的表达没有差别,但其BAX和p21的表达,较含野生型p53的ES细胞少。结论p53249编码子突变可使p53的功能减弱,但对p53的表达没有影响。 [ Objective ] To explore the effect of p53 249 Arg to Ser mutation on the cell cycle arrest and apoptosis induced by IR in mouse ES cell. [Methods ] Arg to Ser mutation were introduced into the p53 249 code by knock-in method, the ES cell with p53 249 Arg to Ser mutation were selected according to the homologues-reeombination with PCR and Southern blot. The positive ES were treated with IR, and the cell cycle, apoptosis, and the relative protein expressions were analyzed by flow cytometry and Western blot. [ Results ] (1)The ES cell with 249 Arg to Ser mutation were more resistant to IR induced cell cycle arrest compared to the wild type ES cell, P 〈0.05. (2)The ES cell with 249 Arg to Ser mutation were more resistant to the IR induced apoptosis compared to the wild type ES cell, P 〈0.05. (3)The mutation did not effect the expression of p53 after IR, but decreased the expression of BAX and p21 after IR. [Conclusion] The p53 249 Arg to Ser mutation can disable the function of p53, but do not change the expression of p53.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2009年第22期3365-3367,3373,共4页 China Journal of Modern Medicine
基金 国家自然科学基金资助项目(No:30572101)
关键词 肝癌 发病机制 抑癌基因P53 hepatoma carcinogenesis tumor suppressor p53
  • 相关文献

参考文献2

二级参考文献21

  • 1J萨姆布鲁克 DW拉塞尔.著.黄培堂 等.译.分子克隆实验指南.第2版[M].北京:科学出版社,2002.38-64.
  • 2Yang X,Khosravi-Far R,Chang HY,et al.Daxx,a novel Fas-binding protein that activates JNK and apoptosis.Cell,1997,89:1067-1076.
  • 3Kiriakidou M,Driscoll DA,Lopez-Guisa JM,et al.Cloning and expression of primate Daxx cDNAs and mapping of the human gene to chromosome 6p21.3 in the MHC region.DNA Cell Biol,1997,16:1289-1298.
  • 4Villunger A,Huang DC,Holler N,et al.Fas ligand-induced c-Jun kinase activation in lymphoid cells requires extensive receptor aggregation but is independent of DAXX,and Fas-mediated cell death does not involve DAXX,RIP,or RAIDD.J Immunol,2000,165:1337-1343
  • 5Michaelson JS,Bader D,Kuo F,et al.Loss of Daxx,a promiscuously interacting protein,results in extensive apoptosis in early mouse development.Genes Dev,1999,13:1918-1923.
  • 6Li H,Leo C,Zhu J,et al.Sequestration and inhibition of Daxx-mediated transcriptional repression by PML.Mol Cell Biol,2000,20:1784-1796.
  • 7BOLDRINI L, FAVIANA P, GISFREDI S, et al. Identification of FAS (APO-1/CD95)and p53 gene mutations in non-small cell lungcancer[J]. Inter Oncol, 2002, 20(1): 155-159.
  • 8THOMPSON CB. Apoptosin the pathogenesis and treatment of disease[J]. Science, 1995, 267: 145-153.
  • 9WANG Q, BECK WT. Transcriptional suppression of muhidrug resistance-associatal protein (MRP) gene expression by wild-type p53[J]. Cancer Res, 1998, 58: 5762-5769.
  • 10SULLIVAN GF, YANG JM, VASSIL A, et al. Regulation of expression of the multidrugcells.resistance protein MRP1 by p53 in human prostate cancer[J]. J Clin Invest, 2004, 105: 1261-1267.

共引文献16

同被引文献10

  • 1廖子君,宋永春,陈晓泉.大黄素对人肺腺癌A-549细胞增殖周期影响的实验研究[J].中华肿瘤防治杂志,2007,14(5):342-344. 被引量:26
  • 2孙燕.肿瘤的发生情况与防治趋势.中国医学论坛报,2002,28(45):14-16.
  • 3Anand P, Thomas SG, Kunnumakkara AB, et al. Biological activities of curcumin and its analogues (congeners) made by man and mother nature [ J ]. Biochem Pharmacol, 2008, 76 (11) :1590-1611.
  • 4Moragoda L,Jaszewski R,Majumdar AP. Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells[J]. Anticancer Res,2001,21 (2A) :873 -878.
  • 5Fridman JS, Lowe SW. Control of apoptosis by p53 [ J]. Oncogene, 2003, 33:9030 -9040.
  • 6Sfivastava RK, Chen Q, Siddiqui I, Sarva K, Shankar S. Linkage of curcumin - induced cell cycle arrest and apoptosis by cyclindependent kinase inhibitor p21 (/WAF1/CIP1) [J]. Cell Cycle,2007, 6(23) :2953 -2961.
  • 7Doral T, Gehani N, Katz A. Therapeutic potential of eureumin in human prostate cancer. II. Curcumin inhibits tyresine kinase activity of epidermal growth factor receptor and depletes the protein[J]. Mol Urol,2000, 4(1):1 -6.
  • 8许建华,赵蓉,柯丹如.姜黄素的体外抗癌作用及其水溶液的稳定性[J].中国药理学通报,1998,14(5):415-417. 被引量:42
  • 9韩婷,宓鹤鸣.姜黄的化学成分及药理活性研究进展[J].解放军药学学报,2001,17(2):95-97. 被引量:143
  • 10崔淑香,金东庆,周玲,侯金玲,朱燕,宋守芹,曲显俊.姜黄素抗肿瘤作用试验观察[J].肿瘤防治杂志,2002,9(1):50-52. 被引量:20

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部